rxstatShortages › Ioversol

Ioversol (Optiray) shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ioversol is in a widespread shortage in Canada. 2 of 2 reported products are affected. Manufacturers have not committed to a recovery date.

A contrast agent injected during X-ray and CT scans to make blood vessels and organs visible.

Products affected
2 / 2
In shortage since
Jul 15, 2022
Reports on file
6
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Estimated end date remains unknown, waiting for supply from manufacturer.
Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Estimated end date remains unknown, waiting for supply from manufacturer
Active shortage
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 02035626 · since Oct 29, 2024, no end estimate · This pre-filled syringe version is not marketed.
Active shortage
OPTIRAY 320
68% · SOLUTION · LIEBEL-FLARSHEIM COMPANY LLC
DIN 01900854 · since Jul 15, 2022, no end estimate · Shortage of an active ingredient.
Resolved
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM CANADA INC
DIN 02035626 · ended Jan 17, 2020 · Disruption of the manufacture of the drug.
Resolved
OPTIRAY 320 (ULTRAJECT)
68% · SOLUTION · LIEBEL-FLARSHEIM CANADA INC
DIN 02035626 · ended Jan 17, 2020 · Disruption of the manufacture of the drug.

What's happening

Ioversol is currently affected by 2 active shortage reports filed with Health Canada by LIEBEL-FLARSHEIM COMPANY LLC.

The reported causes are: estimated end date remains unknown, waiting for supply from manufacturer; estimated end date remains unknown, waiting for supply from manufacturer; this pre-filled syringe version is not marketed; shortage of an active ingredient. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ioversol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).

Recent changes

Common questions

What is Ioversol used for?

A contrast agent injected during X-ray and CT scans to make blood vessels and organs visible.

When will Ioversol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ioversol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (x-ray contrast media, iodinated)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.